Total Payments
$1,111
2024 Payments
$13.48
Companies
21
Transactions
38
Medicare Patients
1,888
Medicare Billing
$217,016
Payment Breakdown by Category
Food & Beverage$1,046 (94.2%)
Education$64.65 (5.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,046 | 36 | 94.2% |
| Education | $64.65 | 2 | 5.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LivaNova USA, Inc. | $190.93 | 4 | $0 (2019) |
| Eisai Inc. | $186.76 | 4 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $152.63 | 2 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $139.12 | 2 | $0 (2019) |
| UCB, Inc. | $82.51 | 5 | $0 (2020) |
| US WorldMeds, LLC | $61.80 | 2 | $0 (2019) |
| Grifols USA, LLC | $51.01 | 3 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $33.79 | 2 | $0 (2019) |
| Alexion Pharmaceuticals, Inc. | $24.89 | 2 | $0 (2020) |
| GENZYME CORPORATION | $24.12 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.48 | 1 | Boston Scientific Corporation ($13.48) |
| 2023 | $12.98 | 1 | Puma Biotechnology, Inc. ($12.98) |
| 2022 | $17.23 | 1 | Mallinckrodt Hospital Products Inc. ($17.23) |
| 2021 | $156.72 | 3 | Teva Pharmaceuticals USA, Inc. ($125.00) |
| 2020 | $81.27 | 5 | UCB, Inc. ($35.07) |
| 2019 | $590.36 | 19 | LivaNova USA, Inc. ($172.81) |
| 2018 | $92.36 | 5 | Grifols USA, LLC ($32.05) |
| 2017 | $146.24 | 3 | Sunovion Pharmaceuticals Inc. ($121.82) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/12/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: WATCHMAN_IC | ||||||
| 07/12/2023 | Puma Biotechnology, Inc. | NERLYNX (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: ONCOLOGY | ||||||
| 02/24/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2021 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $19.58 | General |
| Category: Neurology | ||||||
| 07/15/2021 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Central Nervous System | ||||||
| 06/15/2021 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/19/2020 | Upsher-Smith Laboratories LLC | TOSYMRA SUMATRIPTAN NASAL SPRAY (Drug), ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: NEUROLOGY | ||||||
| 03/03/2020 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Neurology | ||||||
| 02/11/2020 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $16.56 | General |
| Category: AED | ||||||
| 01/15/2020 | Alexion Pharmaceuticals, Inc. | Soliris (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Immunology | ||||||
| 01/13/2020 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Neurology | ||||||
| 12/08/2019 | EISAI INC. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $48.05 | General |
| Category: Neurology | ||||||
| 12/07/2019 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $96.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2019 | GE HEALTHCARE | — | Food and Beverage | Cash or cash equivalent | $14.62 | General |
| 12/04/2019 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Neurology | ||||||
| 11/20/2019 | Sunovion Pharmaceuticals Inc. | — | Education | In-kind items and services | $17.30 | General |
| Category: APL-130277 | ||||||
| 10/17/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: NEUROLOGY | ||||||
| 10/09/2019 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 10/07/2019 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Immunology | ||||||
| 09/18/2019 | US WorldMeds, LLC | Xadago (Drug), MYOBLOC, APOKYN | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Neurology | ||||||
| 09/11/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $14.36 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 09/04/2019 | US WorldMeds, LLC | Xadago (Drug) | Education | In-kind items and services | $47.35 | General |
| Category: Neurology | ||||||
| 08/21/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: NEUROLOGY | ||||||
| 08/07/2019 | EISAI INC. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $110.43 | General |
| Category: Neurology | ||||||
| 07/25/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 290 | 320 | $101,971 | $40,604 |
| 2022 | 8 | 337 | 360 | $85,360 | $33,014 |
| 2021 | 13 | 541 | 639 | $151,197 | $60,648 |
| 2020 | 12 | 720 | 896 | $203,680 | $82,751 |
Total Patients
1,888
Total Services
2,215
Medicare Billing
$217,016
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 137 | 137 | $55,622 | $21,845 | 39.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 45 | 60 | $17,580 | $7,955 | 45.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 40 | $8,640 | $3,813 | 44.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 25 | 33 | $7,161 | $2,934 | 41.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 20 | $8,440 | $2,567 | 30.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 14 | $2,128 | $845.46 | 39.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 16 | 16 | $2,400 | $645.00 | 26.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 98 | 101 | $39,188 | $14,874 | 38.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 59 | 59 | $15,655 | $6,038 | 38.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 66 | 73 | $10,039 | $3,879 | 38.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 26 | 35 | $6,930 | $2,760 | 39.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 23 | 23 | $6,170 | $2,411 | 39.1% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 16 | 16 | $3,104 | $1,235 | 39.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 37 | 40 | $3,000 | $1,141 | 38.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 12 | 13 | $1,274 | $675.33 | 53.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 164 | 170 | $65,960 | $25,647 | 38.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 93 | 132 | $18,084 | $7,330 | 40.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 39 | 62 | $12,276 | $4,788 | 39.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 31 | 46 | $9,430 | $4,241 | 45.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 29 | 29 | $9,367 | $4,188 | 44.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 30 | 32 | $8,416 | $3,305 | 39.3% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 14 | 20 | $8,040 | $3,058 | 38.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 17 | $4,658 | $2,156 | 46.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 60 | 62 | $4,650 | $1,819 | 39.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $4,424 | $1,529 | 34.6% |
About Dr. Muhammad Bilal, MD
Dr. Muhammad Bilal, MD is a Neurology healthcare provider based in Avon, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2013. The National Provider Identifier (NPI) number assigned to this provider is 1417290057.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhammad Bilal, MD has received a total of $1,111 in payments from pharmaceutical and medical device companies, with $13.48 received in 2024. These payments were reported across 38 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,046).
As a Medicare-enrolled provider, Bilal has provided services to 1,888 Medicare beneficiaries, totaling 2,215 services with total Medicare billing of $217,016. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology, Epilepsy
- Location Avon, IN
- Active Since 04/02/2013
- Last Updated 01/07/2026
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1417290057
Products in Payments
- VNS Therapy (Device) $190.93
- Fycompa (Drug) $186.76
- AJOVY (Biological) $125.00
- LATUDA (Drug) $121.82
- Briviact (Drug) $67.95
- Xadago (Drug) $61.80
- Gamunex-C (Biological) $51.01
- INGREZZA (Drug) $33.79
- AJOVY (Drug) $27.63
- AUBAGIO (Drug) $24.12
- TOSYMRA SUMATRIPTAN NASAL SPRAY (Drug) $17.84
- ACTHAR (Biological) $17.23
- BOTOX COSMETIC (Biological) $16.92
- TROKENDI XR (Drug) $16.56
- Betaseron (Drug) $15.72
- Vimpat (Drug) $14.56
- ANDEXXA (Biological) $14.36
- WATCHMAN Access System (Device) $13.48
- SOLIRIS (Drug) $13.09
- NERLYNX (Drug) $12.98
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Avon
Christopher Wilson, Md, MD
Neurology — Payments: $437,965
Neurology $437,965
Kylene Huler, M.d, M.D
Neurology — Payments: $4,416
Neurology $4,416
Yolanda Pena, Md, MD
Neurology — Payments: $2,417
Neurology $2,417
James Fesenmeier, Md, MD
Neurology — Payments: $651.62
Neurology $651.62
Ruth Baird, Md, MD
Neurology — Payments: $463.60
Neurology $463.60
Sadia Saba, Md, MD
Neurology — Payments: $95.30
Neurology $95.30